Skip to main content

Portfolio

Investment Principles
Investment Area
Investment Process
Portfolio
Project title
Research institute
Preclinical
Phase1
Phase2
Phase3
Licensure
Manufacturing Process development for an inactivated Rotavirus Vaccine using attenuated CDC-9 strain
●
Schistosomiasis Vaccine
●
●
Typhoid Conjugate Vaccine
●
●
Measles-Rubella MAP Vaccine
●
Group A Streptococcus Vaccine
●
Technology Transfer of Pentavalent Meningitis Conjugate Vaccine
●
●
●
Pentavalent Meningococcal Conjugate vaccine
●
●
●
Non-replicating Protein Nanoparticle-based Rotavirus Vaccine
●
Novel Cholera Conjugate Vaccine
●
Manufacturing Process development for an inactivated Rotavirus Vaccine using attenuated CDC-9 strain
Development stage:
Phase1
Schistosomiasis Vaccine
Development stage:
Phase1, Phase2
Typhoid Conjugate Vaccine
Development stage:
Phase2, Phase3
Measles-Rubella MAP Vaccine
Development stage:
Preclinical
Group A Streptococcus Vaccine
Development stage:
Preclinical
Technology Transfer of Pentavalent Meningitis Conjugate Vaccine
Development stage:
Phase2, Phase3, Licensure
Pentavalent Meningococcal Conjugate vaccine
Development stage:
Phase2, Phase3, Licensure
Non-replicating Protein Nanoparticle-based Rotavirus Vaccine
Development stage:
Preclinical
Novel Cholera Conjugate Vaccine
Development stage:
Phase2
Project title
Research institute
Preclinical
Phase1
Phase2
Phase3
Licensure
Oxfendazole tablet formulation for Onchocerciasais
Continuous Manufacturing Process for Human Use Helminth Infection Treatment
●
●
Novel Antibiotic Combinations to Address AMR Burden in Neonatal Sepsis
●
●
Treatment Development for Severe Malaria
●
Oxfendazole tablet formulation for Onchocerciasais
Development stage :
Other (Formulation development)
Continuous Manufacturing Process for Human Use Helminth Infection Treatment
Development stage :
Phase2, Phase3
Novel Antibiotic Combinations to Address AMR Burden in Neonatal Sepsis
Development stage :
Phase3, Licensure
Treatment Development for Severe Malaria
Development stage :
Phase1
*WHO licensure prequalification
Project title
Research institute
Early Prototype Development/ Analytical Validation
Clinical Validation/ Usability Assessment
Licensure
Quantitative G6PD test
●
●
AI-driven All-in-one Diagnostic Platform for Malaria Species Differentiation
●
●
POCT for COVID19, Influenza and RSV
●
●
POCT for Multidrug-Resistant TB
●
Rapid Diagnostic Test for Malaria Antigen
●
POCT for Sexually Transmitted Infections and Resistance
●
●
●
Handheld POCT for Sexually Transmitted Infections
●
POCT for Sexually Transmitted Infections
●
Rapid Diagnostic Test for Malaria Detection in Saliva Samples
●
●
Quantitative G6PD test
Development stage:
Clinical Validation/ Usability Assessment
AI-driven All-in-one Diagnostic Platform for Malaria Species Differentiation
Development stage:
Clinical Validation/ Usability Assessment, Licensure
POCT for COVID19, Influenza and RSV
Development stage:
Clinical Validation/ Usability Assessment
POCT for Multidrug-Resistant TB
Development stage:
Clinical Validation/ Usability Assessment
Rapid Diagnostic Test for Malaria Antigen
Development stage:
Clinical Validation/ Usability Assessment
POCT for Sexually Transmitted Infections and Resistance
Development stage:
Clinical Validation/ Usability Assessment
Handheld POCT for Sexually Transmitted Infections
Development stage:
Early Prototype Development/ Analytical Validation
POCT for Sexually Transmitted Infections
Development stage:
Early Prototype Development/ Analytical Validation
Rapid Diagnostic Test for Malaria Detection in Saliva Samples
Development stage:
Clinical Validation/ Usability Assessment
No information yet.
Project title
Research institute
Study Area / Country
Analyzing Digital Solutions for Health System Gaps in Crisis-Affected Areas
Ethiopia, Nepal, Kiribati
Quantifying the Added Value of Lunit Software in Advancing TB Elimination Efforts
Vietnam
Understanding the End-user Perspectives of Implementing TB-CAD in High TB Burden Settings and Improving Fitness-for-Use in Children
Mongolia, Vietnam
Analyzing Digital Solutions for Health System Gaps in Crisis-Affected Areas
Study Area / Country :
Ethiopia, Nepal, Kiribati
Quantifying the Added Value of Lunit Software in Advancing TB Elimination Efforts
Study Area / Country :
Vietnam
Understanding the End-user Perspectives of Implementing TB-CAD in High TB Burden Settings and Improving Fitness-for-Use in Children
Study Area / Country :
Vietnam, Mongolia

Receive RfP updates from the RIGHT Foundation by e-mail